Clinical trial Recruiting at 1 site Interventional Ages 14 to 18

Stratified-care school program for teens with suicidal thoughts

Official title: Acceptability and Feasibility of a Stratified-Care School-Based Intervention for Adolescent Suicidal Ideation in Chile: A Study Protocol

Run by Universidad de los Andes, Chile · NCT07063914 · Data updated 2026-11-12

This program will try a stepped CBT approach using Reframe-IT+ for teens with mild/moderate depression and CARIBOU for those with severe depression to reduce suicidal thoughts in high-school students in vulnerable Santiago schools.

Quick facts

Study typeInterventional
Ages14 Years to 18 Years
SexAll
Enrollment60 (estimated)
SponsorUniversidad de los Andes, Chile
Academic / other
Locations1 site (Santiago, Las Condes)
StatusRecruiting
StartedJune 25, 2025
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedAugust 1, 2025
Trial IDNCT07063914 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are students enrolled in grades I–III Medio at participating Santiago schools who report suicidal ideation in the past month (C-SSRS ≥ 3) and meet the PHQ-9 cutoffs for either the Reframe-IT+ (PHQ-9 < 20) or CARIBOU (PHQ-9 ≥ 20) program.

Probably not a fit

Students not enrolled in the participating schools or grades, those without recent suicidal ideation, or those already engaged in a structured suicide-prevention program may not receive benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-arm, quasi-experimental project delivering a culturally adapted stratified-care model in six secondary schools in Santiago, Chile, with pre-post measurements and follow-ups at 3, 6, 9, and 12 months. Students with recent suicidal ideation are screened with the C-SSRS and PHQ-9 and are routed to Reframe-IT+ if their PHQ-9 is below 20 or to CARIBOU if their PHQ-9 is 20 or higher. Both interventions are individually delivered, CBT-based programs adapted for the local context and aimed at reducing depressive symptoms and suicidal ideation. The study focuses on schools with high socioeconomic vulnerability and collects outcome data over one year to measure change.

Why it matters

Potential benefit: If successful, the program could reduce suicidal thoughts and depressive symptoms by providing timely, severity-matched CBT interventions delivered in schools.

How similar studies have gone: Previous school-based CBT programs including earlier Reframe-IT and CARIBOU work have shown promising reductions in depressive symptoms and suicidal ideation, though using a stratified-care matching by severity in this setting is less commonly tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Inclusion Criteria for Educational Institutions

  * Located in Santiago, Chile.
  * Secondary education level (grades I-IV Medio).
  * Coeducational schools.
  * At least two classes per grade level in secondary education.
  * A minimum of 30 students per class.
  * Socioeconomic vulnerability level of ≥ 50%, as measured by the School Vulnerability Index (Índice de Vulnerabilidad Escolar - IVE-SINAE), which includes factors such as parental education and total household income.

Inclusion Criteria for Students

* Enrolled in grades I, II, or III Medio.
* Suicidal ideation within the past month, defined as a score ≥ 3 on the Columbia-Suicide Severity Rating Scale (C-SSRS).
* For the Reframe-IT+ program: mild or moderate depressive symptoms, defined as a PHQ-9 score \< 20.
* For the CARIBOU program: severe depressive symptoms, defined as a PHQ-9 score ≥ 20.

Exclusion Criteria:

* Exclusion Criteria for Students

  * Participation in a structured suicide prevention program (Reframe-IT+) during 2024.
  * Severe psychotic symptoms, such as perceptual disturbances or delusional ideas, assessed during the eligibility interview.
  * Suicide attempt(s) in the past three months, assessed during the eligibility interview.

Where it's running

  • Universidad de los Andes
    Santiago, Las Condes, Chile
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.